FDA Approved: LENALIDOMIDE — Original Application (EXELAN PHARMACEUTICALS INC.)

View source ↗

Summary

FDA approves a generic lenalidomide product from Exelan Pharmaceuticals under an original application. The drug is indicated for several hematologic cancers and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelodysplastic Syndromes with 5q Deletion
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

ORIG AP for LENALIDOMIDE (LENALIDOMIDE)